Newsroom

Sorted by: Latest

-

DOCS Dermatology Group Secures Refinancing and Upsizing from Penfund, Antares and New Mountain; Appoints President and CFO to Support Growth Expansion

CINCINNATI--(BUSINESS WIRE)--DOCS Dermatology Group Secures Refinancing and Upsizing from Penfund, Antares and New Mountain; Appoints President and CFO to Support Growth Expansion...
-

Wilson James Selects Legion’s AI-Powered Workforce Management Platform to Transform Workforce Operations

LONDON--(BUSINESS WIRE)--Wilson James, a leading integrated solutions provider operating across aviation, security, infrastructure, and logistics, has selected Legion’s AI-powered Workforce Management (WFM) platform as part of a strategic transformation to redefine how complex, people-led operations are planned, managed, and optimised across its UK and international divisions. Operating in some of the most demanding and highly regulated environments in the country, Wilson James delivers critica...
-

NewEdge Advisors Partners with $6 Billion Stonegate Investment Group

PITTSBURGH--(BUSINESS WIRE)--NewEdge Capital Group, LLC, announced today that Stonegate Investment Group of Birmingham, Alabama has affiliated with its NewEdge Advisors RIA. The transaction has enabled NewEdge Advisors’ Pillar Channel program to surpass $14 billion in client assets. Stonegate’s 13-person advisory team oversees approximately $6 billion in client assets and is the largest team to affiliate through the NewEdge Advisor Pillar Channel. NewEdge Advisors is a growth-oriented RIA suppo...
-

EDO TV Outcomes Report: Women’s Sports Cement Cultural Impact in 2025, Outperforming Primetime for Second Straight Year

NEW YORK--(BUSINESS WIRE)--Women’s sports advertising continues to outperform primetime TV, according to the third annual Women’s Sports TV Outcomes Report from EDO, the TV outcomes company. Women’s sports ads generated 15% more impact than the average ad on primetime broadcast and cable, marking the second consecutive year this programming has exceeded the benchmark. From NCAA basketball, lacrosse, and gymnastics to U.S. Open tennis and the WNBA, women’s sports are an exciting and rich platfor...
-

WHOOP Broadens WHOOP Advanced Labs Offering, Announcing a Women’s Health Specialized Blood Biomarker Panel

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today unveiled multiple initiatives and new clinically-backed features, including the coming launch of the company’s Women's Health Specialized Blood Biomarker Panel. Building on the WHOOP Advanced Labs Baseline Panel launched last year, the Women’s Health Specialized Blood Biomarker Panel adds 11 clinically backed, female-specific blood biomarkers that expand insight into areas that are frequently under-measured or misinterpreted i...
-

Terra Security Appoints Anna Sarnek as Vice President of Business & Strategy to Accelerate Ecosystem-Led Growth

NEW YORK--(BUSINESS WIRE)--Terra Security appoints Anna Sarnek as Vice President of Business & Strategy....
-

Flip Electronics Names Todd McAtee as Global Chief Revenue Officer

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--O2 Investment Partners is pleased to announce that Flip Electronics has named Todd McAtee as Global Chief Revenue Officer....
-

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on March 30, 2026. The Circular is available under Organigram’s profile on SEDAR+ at ww...
-

Alzheon to Present Clinical, Imaging, and Fluid Biomarker Results from Trials with Oral Valiltramiprosate/ALZ-801 at 2026 AD/PD Conference in Copenhagen, Denmark

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced it will present new efficacy, imaging, safety, biomarker, and quantitative systems pharmacology findings for its lead investigational therapy, valiltramiprosate/ALZ-801 during the 2026 International Conference on Alzheimer’s an...
-

TTNE kündigt World Sauna Award „SAUNA37 2026“ an

TOKIO--(BUSINESS WIRE)--TTNE Inc. hat heute „SAUNA37 2026“ bekannt gegeben, einen weltweiten Sauna-Award, mit dem 37 Sauna-Destinationen rund um den Globus ausgezeichnet werden Mit dieser Initiative wollen wir zum weltweiten Wachstum der Saunakultur beitragen und eine Zukunft schaffen, in der Menschen auf der ganzen Welt durch Saunas ein glücklicheres und gesünderes Leben führen können. TTNE wurde von Totonoe Oyakata (Dai Matsuo) und Sauna Master (Daisuke Akiyama) gegründet, die persönlich eini...